Thiobarbituric acid reactive substances as an index of lipid peroxidation in sevoflurane-treated rats;Determinação das substâncias reativas ao ácido tiobarbitúrico como indicador da peroxidação lipídica em ratos tratados com sevoflurano

Revista Brasileira de Anestesiologia

Volumn 54, Issue 5, 2004, Pages 640-649

  Lucena Bezerra, Francisco José ^a,c   Rezende, Adriana Augusto ^b   Rodrigues, Sara Jane ^b   Almeida, Maria Das Graças ^b  

^a Hosp Univ Onofre Lopes da UFRN   (Brazil)

^b Centro de Ciencias da Saude da UFRN

^c NONE   (Brazil)

Author keywords

Anesthetics, Volatile: sevoflurane; Animal: rat; Drugs: isoniazid; Metabolism: lipid peroxidation

Indexed keywords

CYTOCHROME P450 2E1; ENZYME INDUCING AGENT; ISONIAZID; OXYGEN; SEVOFLURANE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG TRANSFORMATION; HISTOLOGY; LIPID PEROXIDATION; LIVER NECROSIS; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; RAT;

EID: 5044237501     PISSN: 00347094     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-70942004000500004     Document Type: Article

References (30)

1. Ferreira ALA, Matsubara SL - Radicals livres: conceitos, doenças relacionadas, sistema de defesa e estresse oxidativo. Rev Ass Med Brasil, 1997;43:61-68.
2. Durak I, Guven T, Birey M et al - Halothane hepatotoxicity and hepatic free radical metabolism in guinea pigs: the effects of vitamin E. Can J Anaesth, 1996;43:741-748.
3. Durak I, Ozturk HS, Dikmen B et al - Isoflurane impairs antioxidant defence system in guinea pig kidney. Can J Anaesth, 1999;46:797-802.
4. Delfino J, Vale NB, Magalhães E et al - Estudo comparative entre sevoflurano e halotano para cirurgia pediátrica de curta duração. Rev Bras de Anestesiol, 1997;47:10-15.
5. Goa KL, Noble S, Spencer CM - Sevoflurane in paediatricanaesthesia: a review. Paediatr Drugs, 1999;1:127-153.
6. Kenna JG, Jones RM - The organ toxicity of inhaled anesthetics. AnesthAnalg, 1995;81:(Suppl)S51-S66.
7. Shayiq RM, Raza H, Kidwai AM - Fluoride and lipid peroxidation: a comparative study in different rat tissues. Bull Environ Contam Toxicol, 1986;37:70-76.
8. Dai Y, Rashba-Step J, Cederbaum AI - Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry, 1993;32:6928-6937.
9. Bernheim F, Bernheim MLC, Wilbur KM - The reaction between thiobarbituric acid and the oxidation products of certain lipids. J Biol Chem, 1948;174:257-264.
10. Sato N, Fujii K, Yuge O - In vivo and in vitro sevoflurane-induced lipid peroxidation in guinea-pig liver microsomes. Pharmacol Toxicol, 1994;75:366-370.
11. Kundu D, Hallinan T - Fluoride or GTP-gamma-S markedly stimulate lipid peroxidation catalysed by endogenous iron in rat liver microsomes. Biochem Soc Trans, 1995;23:541S.
12. Ekstrom G, Ingelman-Sundberg M - Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol, 1989;38:1313-1319.
13. Arimoto T, Yoshikawa T, Takano H et al - Generation of reactive oxygen species and 8-hydroxy-2′-deoxyguanosine formation from diesel exhaust particle components in L1210 cells. Jpn J Pharmacol, 1999;80:49-54.
14. Wang J, Zeng YM, Li H - Effects of sevoflurane and halothane on contracture function, SOD activity, MDA content on isolated ischemic rat hearts. Anesthesiology, 1997;87:3A.
15. Allaouchiche B, Debon R, Goudable J et al - Oxidative stress status during exposure to propofol, sevoflurane and desflurane. Anesth Analg, 2001;93:981-985.
16. Wood CL, Gandolfi AJ, Van Dyke RA - Lipid biding of a halothane metabolite. Relationship to lipid peroxidation in vitro. Drug Metab Dispos, 1976;4:305-313.
17. Naziroglu M, Gunay C - The levels of some antioxidant vitamins, glutathione peroxidase and lipoperoxidase during anaesthesia of dogs. Cell Biochem Funct, 1999;17:207-212.
18. Tsuchiya M, Asada A, Kasahara E et al - Antioxidant protection of propofol and its recycling in erythrocyte membranes. Am J Respir Crit Care Med, 2002;165:54-60.
19. Kang MY, Tsuchiya M, Packer L et al - In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand, 1998;42:4-12.
20. Kharasch ED, Frink EJ, Artru A et al - Long-duration low-flow sevoflurane and isoflurane effects on postoperative renal and hepatic function. Anesth Analg, 2001;93:1511-1520.
21. Timbrell JA, Mitchell JR, Snodgrass WR et al - Isoniazid hepatotoxicity: the relationship between covalent binding and metabolism in vivo. J Pharmacol Exp Ther, 1980;213:364-369.
22. Mitchell JR, Zimmerman HJ, Ishak KG et al - Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med, 1976;84:181-192.
23. Rice SA, Sbordone L, Mazze RI - Metabolism by rat hepatic microsomes of fluorinated ether anesthetics following isoniazida administration. Anesthesiology, 1980;53:489-493.
24. Walubo A, Smith P, Folb PI - The role of oxygen free radicals in isoniazida-induced hepatotoxicity. Methods Find Exp Clin Pharmacol, 1998;20:649-655.
25. Sarich TC, Zhou T, Adams SP et al - A model of isoniazid-induced hepatotoxicity in rabbits. J Pharmacol Toxicol Methods, 1995;34:109-116.
26. Bermejo-Alvarez MA, Rodrigues-Dintén MJ, Brime-Casanueva JI et al - Efectos renales de la anestesia prolongada com sevoflurane en ratas Wistar. Rev Esp Anestesiol Reanim, 1999;46:241-246.
27. Yesilkaya A, Ertug Z, Yegin A et al - Deformability and oxidant stress in the red blood cells under the influence of halothane and isoflurane anesthesia. Gen Pharmacol, 1998;31:33-36.
28. Saralakumari D, Rao PR - Erythrocyte glutathione metabolism in human chronic fluoride toxicity. Biochem Int, 1991;23:349-357.
29. Luzzatto L, Mehta A - The Metabolic Basis of Inherited Disease, 2nd Ed, New York McGraw-Hill, 1995; 225-229.
30. Gentz BA, Malan TP - Renal toxicity with sevoflurane: a storm in a teacup? Drugs, 2001;61:2155-2162.